A postdoctoral position is immediately available in the laboratory of Dr. Sang-Ging Ong in the Department of Pharmacology and the Center for Stem Cell and Regenerative Medicine at the University of Illinois at Chicago. The Ong lab is stably funded by the National Heart, Lung, and Blood Institute and institutional funding.
Using mouse models, patients’ samples, and patient-specific induced pluripotent stem cells, the Ong lab seeks to understand the molecular and biological mechanisms underlying various cardiovascular diseases through cellular, genetic, and biochemical approaches. We are currently seeking a candidate to lead a new research program on how post-transcriptional regulation of RNA including RNA modifications lead to metabolic changes in the heart under both physiological and pathological conditions. We are also interested in studying how non-coding RNAs regulate the response of cardiac cells during stress.
Qualifications: Recent or upcoming PhD or MD/PhD degree (must be within 3 years of obtaining PhD) and a strong record of peer-reviewed publications with at least one first-author manuscript (IF>5) in RNA biology, is essential. Ideal candidates should have experience working in two or more of the following areas: 1) stem cell biology/chemical biology, 2) epigenetics/epitranscriptomics, 3) sequencing techniques e.g. ChIP-Seq, MeRIP-seq, and CLIP-seq, 4) RNA biology, genomics or bioinformatics, and 5) gene-editing techniques including CRISPR.
Interested candidates should submit a CV with the names of three referees to Dr. Sang-Ging Ong (email@example.com). The position is open immediately until filled.
The University of Illinois at Chicago is an Equal Opportunity, Affirmative Action employer. Minorities, women, veterans and individuals with disabilities are encouraged to apply. The University of Illinois may conduct background checks on all job candidates upon acceptance of a contingent offer. Background checks will be performed in compliance with the Fair Credit Reporting Act.